About Us

ConSynance Therapeutics is an emerging clinical-stage drug development company based in Albany, New York. With our passion for drug R&D, proven track record, nimble business model and industrial connections both in the US and globally, we believe that we can efficiently and creatively advance new drug candidates for partnering and commercialization.

Our pipeline includes two clinical and one late preclinical programs in metabolic, CNS and digestive disease areas. Through strategic collaborations we will deliver differentiated, first-in-class therapeutics to address important medical needs.